Pain Care Labs’ Advisory Board Member Tiffany Wilson Receives Top Appointment

Former GCMI CEO Named President & CEO of University City Science CenterTiffany Wilson

 

Pain Care Labs congratulates advisory board member Tiffany Wilson on being named president & CEO of University City Science Center in Philadelphia, a non-profit organization with a strong track record of helping entrepreneurs commercialize promising technology and nurture a STEM workforce to support the innovation economy.

According to Pain Care Labs Founder, CEO and research scientist, Amy Baxter, M.D., “Tiffany Wilson has been instrumental in the success of our business, helping us to establish our strategic direction and navigate the complicated world of medical devices. “From our early Global Center for Medical Innovation (GCMI) funding for our needle pain control device, Buzzy®, to sage advice and invaluable introductions and opportunities along the way, Tiffany has shared our passion for reimagining the way pain is treated and managed. We’re proud to have such an incredible resource on our Advisory Board.”

 

Wilson brings nearly 20 years of leadership experience, transitioning innovative medical technologies from idea to market. She most recently served as CEO of Global Center for Medical Innovation (GCMI), an Atlanta-based non-profit dedicated to supporting the development and commercialization of innovative medical products. Wilson’s strong background in medical devices, commitment to fostering innovation and understanding of business strategies propelled her into a leadership role in the Southeast and brought her into the national spotlight.

 

“Dr. Baxter and her team at Pain Care Labs have disrupted the future of pain management through research-based medical devices not only for needle pain but home pain management, post-op and injury-related pain,” observes Wilson. “It is a privilege to be part of the Pain Care Labs Advisory Board as the company navigates growth and new business models to improve patient lives and healthcare outcomes.”

 

Pain Care Labs is grateful for the service of Wilson on its advisory board. Wilson’s talents in the

Support anabolisant pour ceux qui s’intéressent sérieusement au muscle! anabolic trinity n’est pas là pour jouer avec les débutants. C’est une formule anabolique avancée qui vous apporte un triple de la dose de possibilité illimitée! turinabol achat La vérité est que vous pouvez augmenter considérablement la vitesse à laquelle vous développez vos muscles en utilisant les meilleurs suppléments de renforcement musculaire sur le marché aujourd’hui. Le fait est que… avec les milliers de suppléments différents disponibles, il peut être très difficile de choisir ceux qui vous fourniront – et ceux qui ne feront que brûler un trou dans votre portefeuille.

medical device ecosystem complement the diverse skill sets of other members of PCL’s collaborative board.

 

“Working with a practicing physician to successfully launch a disruptive technology in the medical device world has been especially gratifying,” commented Wilson.

 

ABOUT TIFFANY WILSON

Wilson earned a BBA in International Business from Loyola University and an MBA from Georgetown University McDonough School of Business. Wilson joined GCMI from Scientific Intake, where she served as the Vice President of Business Development and Strategy, evaluating marketing and distribution opportunities and driving product development projects for the global obesity market. Prior to Scientific Intake, she was Vice President of Corporate Strategy and Finance at ACell, Inc., a regenerative medicine and tissue engineering company based in Columbia, Maryland. At ACell, she led a broad range of initiatives including corporate finance, investor relations, strategic and operational planning, business development, regulatory, and reimbursement.

 

Wilson serves as Past President of the Board of the Southeast Medical Device Association (SEMDA), Founding Member of Medtech Women @ SEMDA, Chair of the Advisory Board for GCMI’s preclinical testing facility, and as a member of the Georgia Bio Board of Directors. She led the Sponsorship Committee of the 2013 SEMDA Conference and has served as the Co-Chair of the Medical Device Subcommittee of the Metro Atlanta Chamber Bioscience Leadership Council. In 2015 Wilson received the prestigious Georgia Bio Community Award and in 2017 she was presented with the Industry Growth Award, the highest honor bestowed each year by Georgia Bio.

 

ABOUT PAIN CARE LABS

Pain Care Labs is the industry leader in noninvasive pain relief solutions. Buzzy® has been used to block pain for over 37 million needle procedures. VibraCool® is an FDA registered 510(k) cleared device to treat myofascial pain caused by trigger points, restricted motion, and muscle tension. Established in 2006 by emergency physician and pain researcher Amy Baxter M.D., the Company is dedicated to effective, reusable, and affordable solutions for pain. The Company’s award-winning solutions are based on patented Oscillice® M-Stim® , a mechanical stimulation/thermal neuromodulation platform. Pain Care Labs was named “Industry Leader for Localized Pain Relief” by Frost & Sullivan, a leading market research firm. For more information, including a list of published studies, please visit PainCareLabs.com.

Power Over Pain: The smallest things can make the biggest difference for pediatric patients.

Child Friendly Hospital Foundation logoBrenda Sturgeleski and her team at Child-Friendly Hospital Foundation (CFHF) are on a mission to educate nurses, medical support staff and certified child life specialists about how the smallest things can make the biggest difference in a child’s lifetime healthcare journey. Things like using child-friendly language when explaining procedures or entering the room with a sticker or teddy bear can bring the child (and the parent) great comfort and minimize the anxiety and fear that is often associated with a healthcare visit or hospital stay.

 

One of the biggest game-changers that Brenda recently found was the Buzzy® device, invented by world renowned pain care physician Dr. Amy Baxter. The device combines a proprietary frequency of mechanical vibration combined with a cooling sensation to remove more than 70% of the pain when administering an injection or using a needle. Accompanying the device with things like DistrACTION® cards can also contribute to a more positive patient experience.

As a Child Life, Recreational Therapist, Educator and Founder of CFHF, Brenda has heard first-hand from clinicians on how Buzzy is helping them reduce fear and pain for their pediatric patients. According to Brenda, “Nurses, medical support teams, child life specialists and parents often state that Buzzy is a ‘game-changer’ for all needle sticks, and recently even COVID nasal swab testing, making them less painful and scary! The Buzzy device aligns perfectly with our mission for creating positive healthcare experiences for pediatric patients and their caregivers!”

 

How it Works

Buzzy uses natural “gate control” pain relief by confusing the body’s nerves, thereby dulling or eliminating sharp pain. In the same way that rubbing a bumped elbow helps stop the hurt, Buzzy controls acute pain. The premise is that when nerves receive non-painful signals such as vibration or cold, the brain closes the gate on pain signals.

The second part of Buzzy’s efficacy, and the reason it can help even when distant from the site of procedural pain, is called Descending Noxious Inhibitory Control, or DNIC. DNIC is another effective pain control mechanism that uses the brain’s ability to dampen out unwanted signals. Instead of happening right where the nerves are, though, an intense degree of cold can work anywhere on the body. In scientific terms, intense cold activates a supraspinal modulation raising the body’s overall pain threshold.

 

Reversing the Needle Fear Trend

The number of needle fear and fainting episodes in patients who were born after 1983 has skyrocketed, according to a recent report titled Addressing Needle Dred, Fear and Phobia that provides an analysis of needle fear studies completed over the past 50 years. Needle fear and pain directly correlate to a patient’s willingness to follow crucial preventative care measures and medication therapies. It is particularly challenging for children to understand the necessity of some tests and treatments that require multiple injections, and as a result, develop an aversion to receiving medical care that can last a lifetime.

 

According to Amy Baxter MD, FAAP, FACEP, CEO and Founder of Pain Care Labs, “By creating positive healthcare experiences for pediatric patients, we can reverse this trend that has resulted in one in four Americans having needle fear, and improve adherence to critical preventative healthcare practices, such as receiving vaccinations.”

 

CFHF and Pain Care Labs recently announced a partnership that is designed to help get more Buzzy devices into the hands of hospital administrators, clinicians and caregivers who are unable to afford the device.

 

To learn more about how you can support CFHF’s mission of helping to create more positive healthcare experiences for pediatric patients, visit their website or check them out on social media.

 

The Buzzy device is one of several non-invasive, drug-free pain solutions produced by Pain Care Labs. Pain Care Labs is the industry leader in non-invasive pain relief solutions. Buzzy® has been used to block pain for over 37 million needle procedures. VibraCool® is an FDA registered 510(k) cleared device to treat myofascial pain caused by trigger points, restricted motion, and muscle tension. Established in 2006 by emergency physician and pain researcher Amy Baxter M.D., the Company is dedicated to effective, reusable, and affordable solutions for pain. The Company’s award-winning solutions are based on patented Oscillice® M-Stim®, a mechanical stimulation/thermal neuromodulation platform. Pain Care Labs was named “Industry Leader for Localized Pain Relief” by Frost & Sullivan, a leading market research firm. For more information, including a list of published studies, please visit PainCareLabs.com.

 

Read the recent announcement from CFHF and Pain Care Labs.